Navigation Links
Verum.de CEO to Present on International Clinical Trial Regulations at BIOCOM Event
Date:11/9/2012

SAN DIEGO, Nov. 9, 2012 /PRNewswire/ -- The CEO of Verum.de (Verum), a full-clinical service, German-based contract research organization (CRO) with a new office in Carlsbad, Calif. will speak at an upcoming event held by BIOCOM, the large regional life science association, on Tuesday, Nov. 13, 2012 at 7:30 a.m. PST. The session, Legal and Regulatory Update - Health Care Reform and FDA Developments, will feature Verum CEO Christian Sacher presenting about the clinical trial approval process in the European Union and the proposed changes to the EU trial regulations.

(Logo: http://photos.prnewswire.com/prnh/20120807/LA53176LOGO)

Verum joined BIOCOM earlier this year to expand awareness of its flexible and responsive services and its ability to run clinical trial services with Western standards in Central and Eastern European countries (CEE) and former Soviet bloc countries. With more than 25 years experience running clinical trials in Eastern Europe, Sacher is considered a pioneer in the industry. He helped bring ethical committees and Western best practices to trials in the region.

"It is an honor to have the opportunity to speak at BIOCOM as the organization mirrors Verum's values regarding clinical trials," says Christian Sacher. "With both FDA and European regulations constantly changing, we need to help biotech, pharma and device companies stay on top of the latest developments."

Verum recently opened a U.S. office in Carlsbad to assist U.S. clients with international trials. The new office is headed by Kristi Clark, an industry veteran with more than 20 years of pharma and biotech experience in both large and mid-size CROs.

About Verum.de

German-based Verum.de was founded by Christian Sacher and Jutta Minkner (CFO), two industry pioneers with more than 25 years experience running clinical trials in CEE and former Soviet bloc countries. Verum has more than 100 office based employees operating out of eight locations, including its Munich headquarters, and the company offers therapeutic specialties in cardiovascular, neurology, psychiatry, CNS, oncology and pain, among others. Verum started operations in 1992 in CEE countries based on Western ideals and ethical standards. Verum has substantial contacts with local authorities, and is known in CEE for the flexible and responsive services it provides. More information can be found at http://www.verum.de

CONTACT:

Antonia Genov
Clearpoint Agency, for Verum.de
antonia@clearpointagency.com
760-230-2424


'/>"/>
SOURCE Verum.de
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. German-based Contract Research Organization Verum.de Opens US Office to Expand Clinical Study Services in Central and Eastern Europe for American Pharma and Biotech
2. Omthera Pharmaceuticals Presents Data From Analysis Of EVOLVE Trial Showing That Epanova Lowers ApoC-III, A Key Predictor of Cardiovascular Risk
3. Echo Therapeutics Chosen to Present at the 12th Annual Diabetes Technology Meeting
4. Cempra, Inc. to Present at the Jefferies 2012 Global Healthcare Conference in London
5. BioMed Realty To Audio Webcast Company Presentation At Investor Day 2012
6. ProNAi Expands Management Team and Presents Encouraging Phase I Study Results for Lead Cancer Drug at Cancer Meeting
7. 90 Presentations at Leading Radiation Oncology Meeting Demonstrate the Breadth and Depth of Clinical Evidence for Accuray Technologies
8. Cardica To Present At Lazard Capital Markets 9th Annual Healthcare Conference
9. Rigel to Present at Jefferies 2012 Global Healthcare Conference in London
10. Arena Pharmaceuticals to Present at Two Upcoming Investor Conferences
11. Isis Pharmaceuticals To Present At The 2012 Credit Suisse Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... N.J. , June 24, 2016  Collagen ... the design, development and manufacturing of collagen and ... regeneration announced today that Bill Messer ... and Marketing to further leverage the growing portfolio ... medical devices. Bill joins the Collagen ...
(Date:6/24/2016)... , June 24, 2016 The Academy of ... recommendations that would allow biopharmaceutical companies to ... entities that make formulary and coverage decisions, a move ... of new medicines. The recommendations address restrictions ... appear on the drug label, a prohibition that hinders ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology:
(Date:6/27/2016)... Lafayette, California (PRWEB) , ... ... ... a pioneer in the patient payment industry today announced its strategic partnership ... and health system workflows. , The two companies’ proven, proprietary technology combine ...
(Date:6/26/2016)... ... June 27, 2016 , ... Quality metrics are proliferating in cancer care, and ... in the eye of the beholder, according to experts who offered insights and commentary ... of Managed Care. For the full issue, click here . , For the ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/25/2016)... ... 2016 , ... Experts from the American Institutes for Research ... June 26-28, 2016, at the Hynes Convention Center in Boston. , AIR experts ... planning, healthcare costs and patient and family engagement. , AIR researchers will be ...
(Date:6/25/2016)... Viejo, California (PRWEB) , ... June 25, 2016 , ... ... to fit their specific project," said Christina Austin - CEO of Pixel Film Studios. ... fully customizable and all within Final Cut Pro X . Simply select a ...
Breaking Medicine News(10 mins):